Sclerotherapy (hypertonic glucose plus polidocanol) vs sclerotherapy (hypertonic glucose)
Adverse events ‐ matting ( · people with telangiectasias and reticular veins
Sclerotherapy (hypertonic glucose plus polidocanol) showed no clear difference in adverse events ‐ matting ( compared with sclerotherapy (hypertonic glucose) (moderate certainty).
1 finding from 1 review
- RR 0.78 [0.51, 1.2]2 studies · 191 participantsModerate